Vanguard Group Inc - Jun 30, 2025 SCHEDULE 13G/A Report for Iovance Biotherapeutics Inc Common Stock (IOVA)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Iovance Biotherapeutics Inc Common Stock
Symbol: IOVA
Shares outstanding: 334M shares
Disclosed Ownership: 25.1M shares
Ownership: 7.5%
Form type: SCHEDULE 13G/A
Date filed: 7/29/2025, 01:46 PM
Date of event: Jun 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	7.5%	25.1M	0	158K	Ashley Grim	Head of Global Fund Administration